Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 3 - The Untold Story

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

‘Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author

The Guardian - UK

UK junk food ad ban so diluted it may be largely ineffective, experts say

Exclusive: Report suggests only 1% of annual spend on food and drink adverts will be affected after industry lobbying

The Guardian - UK

FDA finds little evidence that a generic drug could help many people with autism

The FDA is approving a generic drug for a very rare genetic disorder, but not for autism

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

'I am so sorry': diabetic driver speaks over pub crash

A diabetic says he made some "very stupid decisions" as he became hypoglycaemic and did not eat before driving into and killing five people including kids.

AAP

Weight-loss drugs alone will not solve UK’s obesity crisis, says Chris Whitty

Chief medical adviser warns of side-effects and calls for action on junk food advertising and making food healthier

The Guardian - UK

Other countries are streets ahead of the UK on childhood obesity. Here’s what they’re doing differently

There could be 227 million obese children worldwide by 2040. But as South Korea and Denmark have shown, it is possible to tackle this crisis, says Devi Sridhar, chair of global public health at the University of Edinburgh

The Guardian - UK

Weight-loss jab could be made for $3 a month, study finds

Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Oprah Winfrey's Stunning Look at 72: Her Paris Fashion Week Moment and GLP-1 Weight Loss Journey

Oprah Winfrey's 50-pound weight loss at 72 using GLP-1 drugs raises questions about affordability and accessibility. Explore her journey and its impact on WeightWatchers and the fashion world.

International Business Times UK

GLP-1s could help curb substance abuse – including alcohol and opioids, new study finds

The Independent UK

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

US study suggests GLP-1s, used to treat type 2 diabetes, could also reduce risk of people already using substances from overdosing

The Guardian - UK

Stopping weight loss jabs could leave users ‘worse off than before’

GLP-1 users likely to regain two-thirds of the weight they lost within a year, study shows

The Independent UK

UK obesity rate one of worst in Europe as 228 million children worldwide will be obese by 2040, report warns

Globally, the number of children living with obesity is set to exceed the number of those who are underweight

The Independent UK

More than 220m children will be obese by 2040 without drastic action, report warns

World Obesity Federation says half a billion children will be overweight and calls on governments to act to create healthier environments

The Guardian - UK

The perfect length of sleep to avoid diabetes, according to experts

Not getting enough sleep is linked to insulin resistance, which can lead to type 2 diabetes

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Weight-loss drugs may help those who suffer from chronic migraines

GLP-1 drugs used for diabetes and weight loss could cut the need for migraine medication by half, a preliminary study suggests

The Independent UK

The quick ‘chairside’ dentist test that could boost diabetes diagnosis rates

Estimates suggest that around 1.3 million people in the UK have type 2 diabetes but are yet to be diagnosed

The Independent UK

GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds

Medical Daily

Ozempic vs Mounjaro: Comparing GLP‑1 Injectable Weight‑Loss Meds, Semaglutide vs Tirzepatide, and Real Side Effects

Discover how Ozempic vs Mounjaro compare as GLP‑1 injectable weight‑loss meds, exploring semaglutide vs tirzepatide differences, effectiveness, and common Ozempic side effects.

Get all your
news in one place.

100's of premium titles.
One news app.

Cycling News

'Easier than getting a bag of sweets from the shops' - Weight loss drugs are everywhere, but are they a recipe for disaster or game changer for cyclists?

Weight loss drugs are more popular than ever, even in cycling, but do the health benefits some are seeing outweigh the risks and dangers, and what does WADA think of them?

The Independent UK

Researchers discover benefits of once-a-day weight loss pill

Academics have hailed an ‘important advancement’ in type 2 diabetes care

The Guardian - UK

New GLP-1 pill helps patients lose up to 8% of body weight, trial shows

Orforglipron led to greater weight loss than semaglutide tablets and could offer more effective oral alternative to jabs

The Independent UK

Nearly one in four US adults with diabetes are unaware they have it

Researchers announced Thursday that they had taken a major stride in treating the chronic disease

The Independent UK

New research challenges link between childhood BMI and obesity risk

Experts say the genetic factors that influence the size of babies may be different to the ones that influence body size as a teen

The Independent UK

The fibre gap: Easy, everyday recipes to boost the nutrient most of us lack

Despite all the talk of gut health, only a tiny proportion of UK adults get enough fibre. These simple, flavour-led recipes show how everyday veg, pulses and leafy greens can quietly boost your intake – without changing how you cook or eat

The Independent UK

The people most likely to use weight loss jabs, according to new research

Almost 80 per cent of private prescriptions for weight loss jabs are for women, research reveals

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Edinburgh

the American Heart Association

The Health Foundation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.